Our heparin products include APIs and injections. Hepalink’s enoxaparin sodium injection is globally recognized for its quality, and has thus far sold over 540 million doses in Europe¹.The product is currently being sold in over 40 countries and regions including the U.S. and the EU, and has been included into national insurance programs in all 13 member countries of the EU, United Kingdom, and Switzerland.


1.Based on 2017-2023 statistics from IQVIA database